Back to top
more

MEDIFAST (MED)

(Delayed Data from NYSE)

$13.19 USD

13.19
144,148

+0.16 (1.23%)

Updated Aug 15, 2025 04:00 PM ET

After-Market: $13.20 +0.01 (0.08%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 27% (180 out of 246)

Industry: Food - Miscellaneous

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

McCormick (MKC) Looks Poised on High Demand, Saving Efforts

by Zacks Equity Research

McCormick (MKC) is on track with the CCI program to boost savings. However, sluggish performance in its Flavor Solution Unit is a concern.

Sanghamitra Saha headshot

5 Top DuPont-Driven Stocks to Counter Stimulus Uncertainty

by Sanghamitra Saha

Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.

Zacks Equity Research

Zacks.com featured highlights include: Zumiez, Installed Building Products, 1-800-FLOWERS.COM, Medifast and Nu Skin

by Zacks Equity Research

Zacks.com featured highlights include: Zumiez, Installed Building Products, 1-800-FLOWERS.COM, Medifast and Nu Skin

Radhika Pujara headshot

Bet on These 5 Top-Ranked Liquid Stocks for Fat Returns

by Radhika Pujara

Here are five top-ranked liquid stocks, including Nu Skin Enterprises (NUS), that investors can snap up for enhancing portfolio returns.

Zacks Equity Research

McCormick's (MKC) Q3 Earnings Beat Estimates, Sales Up Y/Y

by Zacks Equity Research

McCormick's (MKC) third-quarter fiscal 2020 results reflect the impact of higher sales driven by greater at-home consumption amid the pandemic.

Zacks Equity Research

General Mills (GIS) Q1 Earnings & Sales Top Estimates, Up Y/Y

by Zacks Equity Research

General Mills' (GIS) first-quarter fiscal 2021 results reflect improved earnings and sales due to rising demand stemming from increased at-home consumption amid the pandemic.

Zacks Equity Research

Is MEDIFAST INC (MED) Outperforming Other Consumer Staples Stocks This Year?

by Zacks Equity Research

Is (MED) Outperforming Other Consumer Staples Stocks This Year?

Sanghamitra Saha headshot

5 DuPont-Rich Quality Picks to Handle Sudden Sell-Off

by Sanghamitra Saha

Why you should depend on the DuPont technique to pick solid profit-generating stocks.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Target, Medifast, The Scotts Miracle-Gro, Griffon Corp and Stewart Information Services

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Target, Medifast, The Scotts Miracle-Gro, Griffon Corp and Stewart Information Services

Radhika Pujara headshot

4 Promising Top-Ranked Liquid Stocks to Enrich Your Portfolio

by Radhika Pujara

Here are four top-ranked liquid stocks, including Zumiez (ZUMZ), that investors can bank on for alluring returns.

Zacks Equity Research

4 Reasons Why Flowers Foods (FLO) Stock is Worth Relishing

by Zacks Equity Research

Flowers Foods (FLO) is gaining on rising demand amid the pandemic-led higher at-home consumption. The company is also poised to benefit from focus on core strategies.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Virtusa, RH, M/I Homes, Mr. Cooper Group and Medifast

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Virtusa, RH, M/I Homes, Mr. Cooper Group and Medifast

Nalak Das headshot

5 Top-Ranked High-Yielding Growth Stocks for September

by Nalak Das

Volatility may persist for a few more days. However, the worst of Wall Street is long over and the overall market movement should remain positive going forward.

Zacks Equity Research

Favorable Demand Keeps Campbell Soup Afloat Amid Cost Woes

by Zacks Equity Research

Increasing at-home consumption is boosting Campbell Soup's (CPB) sales. However COVID-19 related costs are a burden.

Nalak Das headshot

6 Top-Ranked Stocks That Surged More Than 10% Last Week

by Nalak Das

Several stocks skyrocketed last week and a handful of these were Zacks top-ranked.

Zacks Equity Research

Nomad Foods (NOMD) Catches Eye: Stock Jumps 5.9%

by Zacks Equity Research

Nomad Foods (NOMD) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

Zacks Equity Research

Nomad Foods (NOMD) Catches Eye: Stock Jumps 5.9%

by Zacks Equity Research

Nomad Foods (NOMD) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

Zacks Equity Research

Hain Celestial Gaining, North America Unit a Key Catalyst

by Zacks Equity Research

Hain Celestial's (HAIN) North America unit is performing well on the back of Get Bigger brands. Further, the company is on track with transformation plans.

Zacks Equity Research

Zacks.com featured highlights include: MED, JD, HUM, UFPI and EXPD

by Zacks Equity Research

Zacks.com featured highlights include: MED, JD, HUM, UFPI and EXPD

Zacks Equity Research

Hershey (HSY) Looks Poised on Brand Strength, Pricing Efforts

by Zacks Equity Research

Hershey's (HSY) brands are gaining on focus on innovation and buyouts. Also, the company is seeing sales growth in North America amid the pandemic.

Zacks Equity Research

Has MEDIFAST INC (MED) Outpaced Other Consumer Staples Stocks This Year?

by Zacks Equity Research

Is (MED) Outperforming Other Consumer Staples Stocks This Year?

Sanghamitra Saha headshot

5 Top-Ranked Stocks Picked on DuPont Analysis

by Sanghamitra Saha

Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.

Zacks Equity Research

MGP Ingredients (MGPI) Looks Good: Stock Adds 5.4% in Session

by Zacks Equity Research

MGP Ingredients (MGPI) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Zacks Equity Research

Here is Why Growth Investors Should Buy Medifast (MED) Now

by Zacks Equity Research

Medifast (MED) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Equity Research

Zacks.com featured highlights include: IBP, MED, NUS and LOGI

by Zacks Equity Research

Zacks.com featured highlights include: IBP, MED, NUS and LOGI